Bond investors speed up access to life saving vaccines
Bond investors speed up access to life saving vaccines
31 May 2007
The GAVI Alliance announced today it will distribute almost US$1 billion in funds in 2007, raised by the International Facility for Immunisation (IFFIm) on capital markets to help poor nations prevent life-threatening diseases and strengthen their health systems.
Backed by six European nations, US$1 billion inaugural bond launch responds to yellow fever threat
Geneva, May 31, 2007 - The GAVI Alliance announced today it will distribute almost US$1 billion in funds in 2007, raised by the International Facility for Immunisation (IFFIm) on capital markets to help poor nations prevent life-threatening diseases and strengthen their health systems.
"The speed and efficiency with which GAVI and its partners responded to a yellow fever threat, supported by new funds from the IFFIm, made it possible to prevent this terrible disease from threatening our children," said Professor Kondi Charles Agba, Minister of Health of Togo
Innovative financing for development
As G8 leaders prepare to review their commitments to poor nations, the GAVI announcement reveals the impact that innovative financing for development is having on access to life-saving vaccines for the world's poorest children, consistent with the commitments made at the 2005 G8 Gleneagles Summit.
Launched last year with backing from six European nations-France, Italy, Sweden, Spain, Norway and the United Kingdom-the International Finance Facility for Immunisation (IFFIm) quickly sold US$1 billion in bonds, freeing up new funds for health protection and development. Most recently the GAVI Alliance put IFFIm monies to work in Togo, funding vaccines to prevent an outbreak of highly infectious yellow fever disease, which kills up to 50 percent of those with severe illness.
Yellow fever in Togo
"The speed and efficiency with which GAVI and its partners responded to a yellow fever threat, supported by new funds from the IFFIm, made it possible to prevent this terrible disease from threatening our children," said Professor Kondi Charles Agba, Minister of Health of Togo. In 2007, IFFIm funds will also support immunisation campaigns against measles, polio, maternal and neonatal tetanus, as well as the introduction of a new "five-in-one" vaccine and strengthening of health services in poor nations.
An Italian official said Italy was delighted with reports of the rate at which the IFFIm funds were being put to work. "By scaling up GAVI's activities, we have a much greater chance of meeting our global commitments to dramatically reduce poverty in developing countries by 2015. We also are building on GAVI's experience to implement a second innovative financing mechanism for immunization, the Advanced Market Commitments, which was launched in Rome last February."
MDG 4
"The International Finance Facility for Immunisation is releasing unprecedented resources for childhood immunisation and health system strengthening," noted GAVI Executive Secretary Julian Lob-Levyt, in announcing the 2007 IFFIm funds distribution. "By speeding up access to life-saving technologies and services, IFFIm can play a vital role in helping to meet the UN Millennium Development Goal to reduce child mortality."
In the next 10 years, with the added support of South Africa, which joined as an IFFIm sponsor in March 2007, and other nations, including Brazil, IFFIm is expected to raise a total of $4 billion for health and immunisation programmes, by selling bonds in the international capital markets. The heavily oversubscribed issue of $1 billion in bonds, sold in November 2006, was IFFIm's inaugural bond. His Holiness Pope Benedict XVI and anti-poverty campaigners Bono and Bob Geldof were among IFFIm's first supporters. The World Bank acts as Treasury Manager for IFFIm, including management of its finances and funding strategy and its implementation in the capital markets.
About the GAVI Alliance
Launched in 2000 at the annual meeting of the World Economic Forum in Davos, the GAVI Alliance includes among its partners developing country and donor governments, the World Health Organization (WHO), UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, NGOs, and the Bill & Melinda Gates Foundation. It is estimated that more than 2.3 million early deaths will have been prevented as a result of support by GAVI up to the end of 2006.
GAVI's efforts are critical to achieving the Millennium Development Goal on child health, which calls for reducing childhood mortality by two-thirds by 2015. Of the more than 10 million children who die before reaching their fifth birthday every year, 2.5 million die from diseases that could be prevented with currently available or new vaccines.
About the IFFIm
The International Finance Facility for Immunisation (IFFIm) priced its first ever capital markets financing in November 2006, raising US$1 billion from its inaugural bond issue. Over the next 10 years, IFFIm is expected to provide US$4 billion of financing for immunisation, by raising funds in the capital markets. IFFIm's finances consist of donor payments made from 2006 to 2025. This investment is expected to prevent 5 million child deaths between 2006-2015, and more than 5 million future adult deaths. IFFIm funds will support the work of the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunization), a leading global health partnership that includes UNICEF, the World Health Organization, the World Bank, the Bill & Melinda Gates Foundation, and representatives of the vaccine industry in both industrialised and developing countries.
About the World Bank
The World Bank is Treasury Manager for IFFIm. The World Bank, as IFFIm's agent, manages IFFIm's finances according to prudent policies and standards. This includes IFFIm's funding strategy and its implementation in the capital markets, rating agency and investor outreach, hedging transactions and investment management. The World Bank also coordinates with IFFIm's donors and manages their pledges and payments, as well as IFFIm's disbursements for immunisation and health programmes through the GAVI Alliance.
Latest Press releases
- IFFIm issues NOK600 million Vaccine Bonds
- Kingdom of Norway contributes NOK 600 million to IFFIm
- IFFIm issues sukuk to the Islamic Development Bank
- Helge Weiner-Trapness joins IFFIm Board
- Islamic Development Bank and IFFIm announce plans to collaborate on private placement
- Government of Brazil signs grant agreement for US$ 20 million in support to IFFIm
- Bertrand de Mazières joins IFFIm Board
- Cyrus Ardalan becomes new Chair of IFFIm Board
- IFFIm issues US$ 300 million in 3-year floating rate Vaccine Bonds
- IFFIm issues US$ 500 million in 3-year floating rate Vaccine Bonds
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.
Reflections on IFFIm: an interview with Rachel Turner
14 November 2024